The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
Authors reviewed published data concerning antiviral treatment of liver transplant recipients with 1st generation HCV protease inhibitors (telaprevir and boceprevir). Efficacy and adverse events have been analyzed with peculiar attention to drug-drug interactions between calcineurin inhibitors and H...
Main Authors: | M. Sh. Khubutiya, V. E. Syutkin, N. I. Geyvandova, A. A. Salienko, T. V. Gudzovskaya, M. S. Novruzbekov |
---|---|
Format: | Article |
Language: | English |
Published: |
N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
2016-02-01
|
Series: | Transplantologiâ |
Subjects: | |
Online Access: | https://www.jtransplantologiya.ru/jour/article/view/34 |
Similar Items
-
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C
by: Xavier Forns, et al.
Published: (2016-07-01) -
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
by: Torres HA, et al.
Published: (2014-07-01) -
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir
by: Beatriz Rodríguez-Medina, et al.
Published: (2013-11-01) -
Cutaneous Eruption due to Telaprevir
by: Eduardo Mastrangelo Marinho Falcão, et al.
Published: (2015-09-01) -
TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)